Seeking Alpha

MissionIR's  Instablog

MissionIR
Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
MissionIR
My blog:
MissionIR Blog
  • StemCells, Inc. (STEM) Announces Greg Schiffman As Chief Financial Officer 0 comments
    Nov 15, 2013 1:55 PM | about stocks: STEM

    StemCells, a leading stem cell company currently developing novel cell-based therapeutics for disorders of the central nervous system, announced that Greg Schiffman has been recruited to join its executive team as Chief Financial Officer and Executive Vice President of Finance, effective as of January 1st, 2014. Schiffman will oversee all areas of the Ccompany's financing activities, financial reporting and controls, corporate communications, as well as investor relations.

    A seasoned executive in the healthcare industry, Schiffman has over fifteen years of experience leading financial operations and strategies of international publicly traded companies such as Affymetrix and Applied Biosystems. Most recently, Schiffman held the role of Executive Vice President and CFO of Dendreon Corporation, where he had primary responsibility for capital raising, information technology, financial reporting and controls and investor relations. In April of 2010, Dendreon secured marketing authorization from the U.S. Food and Drug Administration (FDA) for Provenge(NYSE:R), the world's first cell-based autologous immunotherapy for prostate cancer, followed by European Commission authorization in September of 2013.

    "We're delighted to have Greg join StemCells as it transitions to Phase II, clinical proof of concept trials," stated Martin McGlynn, President and Chief Executive Officer of StemCells, Inc. "Greg brings deep experience across all facets of finance and has a long history of helping emerging technology companies efficiently scale their operations, develop and launch new products, and expand into new markets. StemCells has an incredible team and first-in-class technology, and has cemented its position as one of the key technology innovators in the stem cell industry. I am very excited to bring Greg into the Company to build on its momentum and successes to date, and to help prepare the Company for commercial success."

    "StemCells has built its reputation on demanding excellence, world-class science and thoughtful product development," commented Mr. Schiffman. "I believe the Company's technology has the potential to be a game changer in the treatment of a vast range of disorders affecting the CNS, and I am thrilled to join StemCells at such an exciting time for the Company."

    Before entering the healthcare arena, Schiffman held key roles of responsibility with Hewlett Packard, where he acted as controller of its European P.C. manufacturing and distribution operations in Grenoble, France, and in addition as manufacturing manager and controller of its Netmetrix Division. Schiffman earned a bachelor's degree in accounting from De Paul University and an MBA from the Kellogg Graduate School of Management at Northwestern University.

    Schiffman is set to succeed Rodney Young, who has decided to pursue other opportunities. Commenting on the transition, McGlynn said, "Rodney's time with StemCells was one of groundbreaking achievements, such as our successful completion of the first FDA-authorized study of human neural stem cells as well as initiation of the world's first internationally approved study of these cells as a potential treatment for spinal cord injury. We wish Rodney well in his future endeavors and thank him for his service and dedication during his tenure as CFO at StemCells."

    To learn more, please visit stemcellsinc.com

    MissionIR provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit http://disclaimer.missionir.com

    Stocks: STEM
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.